SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.sbmu.ac.ir/

Clinical Trials

Anterior Lens Capsule as a Spacer in the Deep Sclerectomy _ Phacoemulsification

Not Applicable

Active, not recruiting

Conditions: Glaucoma
Cataract

Interventions: Procedure: Non-penetrating deep sclerectomy and phacoemulsification
Procedure: Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior lens capsule

First Posted Date: 2023-06-15

Last Posted Date: 2023-06-15

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 66

Registration Number: NCT05906212

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

The Effect of Amantadine on Post-COVD-19 Fatigue

Phase 2

Not yet recruiting

Conditions: Post-COVID-19 Syndrome

Interventions: Drug: Amantadine

First Posted Date: 2022-12-28

Last Posted Date: 2022-12-28

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 83

Registration Number: NCT05667077

Locations: 🇮🇷
Shohada Tajrish Hospital, Tehran, Iran, Islamic Republic of

MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

Early Phase 1

Completed

Conditions: Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Interventions: Drug: MLC 901
Drug: Placebo

First Posted Date: 2022-11-18

Last Posted Date: 2022-11-18

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 35

Registration Number: NCT05621590

Locations: 🇮🇷
Shahid Beheshti University of Medical Sciences, Shohada Hospital, Tehran, Iran, Islamic Republic of

Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema

Phase 2

Active, not recruiting

Conditions: Diabetic Macular Edema

Interventions: Combination Product: Intravitreal bevacizumab injection with subthreshold micropulse laser
Drug: Intravitreal bevacizumab injection alone

First Posted Date: 2022-10-17

Last Posted Date: 2022-10-17

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 30

Registration Number: NCT05582577

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Pharmacological Treatment of Presbyopia

Early Phase 1

Recruiting

Conditions: Near Vision

Interventions: Drug: Pilocarpine 1.25% Eye drop

First Posted Date: 2022-10-04

Last Posted Date: 2022-10-04

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 75

Registration Number: NCT05564832

Locations: 🇮🇷
Hamideh Sabbaghi, Tehran, Iran, Islamic Republic of

The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction

Phase 2

Conditions: Meibomian Gland Dysfunction

Interventions: Drug: Topical placebo eye drop
Drug: Topical Vitamin D eye drop

First Posted Date: 2022-08-10

Last Posted Date: 2022-08-10

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 56

Registration Number: NCT05495958

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

The Effect of Erythropoietin in the Treatment of Scleral Necrosis

Phase 2

Conditions: Conjunctival and Scleral Avascular Lesions

Interventions: Drug: Erythropoietin prescription
Drug: Prescription of placebo

First Posted Date: 2022-07-27

Last Posted Date: 2022-07-27

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT05476042

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

Home Vision Therapy and Prism Prescription in Presbyopic Persons With Convergence Insufficiency

Not Applicable

Recruiting

Conditions: Convergence Insufficiency

Interventions: Other: conventional placebo
Other: home vision therapy
Other: base in prism prescription

First Posted Date: 2022-04-05

Last Posted Date: 2023-04-25

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 250

Registration Number: NCT05311917

Locations: 🇮🇷
Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Phase 2

Conditions: Macular Edema

Interventions: Drug: intravitreal injection of bevacizumab
Drug: intravitreal injection of bevacizumab with acetazolamide tablets

First Posted Date: 2022-03-22

Last Posted Date: 2022-03-22

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 57

Registration Number: NCT05290948

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

Short Daily Versus Conventional Hemodialysis for COVID-19 Patients

Not Applicable

Completed

Conditions: COVID-19

Interventions: Other: Short daily dialysis

First Posted Date: 2022-01-28

Last Posted Date: 2022-01-28

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 47

Registration Number: NCT05212675

Locations: 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy